510(k) K010668

BAYER DIAGNOSTICS ADVIA CENTAUR RUBELLA IGM ASSAY by Bayer Corp. — Product Code LFX

K010668 is an FDA 510(k) premarket notification submitted by Bayer Corp. for the device "BAYER DIAGNOSTICS ADVIA CENTAUR RUBELLA IGM ASSAY". The FDA issued a decision of Substantially Equivalent on Jul 5, 2001. The device falls under product code LFX (Enzyme Linked Immunoabsorbent Assay, Rubella), a Class II device regulated under 21 CFR 866.3510. Bayer Corp. has 95 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Jul 5, 2001
Date Received
Mar 6, 2001
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Enzyme Linked Immunoabsorbent Assay, Rubella
Device Class
Class II
Regulation Number
866.3510
Review Panel
MI
Submission Type
510(k)

Need the full FDA record for Bayer Corp.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K010668. Report a data issue: hello@regdatalab.com.